Meningococcal disease and travel

Area of Science:

• Public Health
• Infectious Diseases
• Vaccinology

Background:

• Invasive meningococcal disease (IMD) causes significant global morbidity and mortality.
• Fatality rates for meningococcal meningitis remain high (5-10%), with survivors often experiencing long-term neurological deficits.
• Prevention is critical due to the rapid and severe nature of the disease.

Purpose of the Study:

• To highlight the importance of meningococcal vaccination for at-risk individuals and travelers.
• To address the recent shift in epidemic patterns of IMD during the Hajj season, noting the predominance of Neisseria meningitidis serogroup W135.
• To inform about updated health policies requiring vaccination for pilgrims.

Main Methods:

• Review of epidemiological data on meningococcal disease patterns.
• Analysis of public health policy changes regarding vaccination requirements.
• Emphasis on the role of quadrivalent meningococcal vaccines.

Main Results:

• A shift in IMD epidemiology has been observed, with Neisseria meningitidis serogroup W135 becoming predominant during the Hajj season.
• The Saudi Ministry of Health has implemented new policies requiring proof of vaccination against meningitis for all Hajj and Umra visitors.
• Quadrivalent meningococcal vaccination is recommended for high-risk groups and travelers.

Conclusions:

• Updated vaccination policies are essential to control the spread of IMD, particularly serogroup W135, during mass gatherings like Hajj and Umra.
• Meningococcal vaccination remains a key strategy for preventing severe disease, mortality, and long-term sequelae.
• International travelers and individuals with specific medical conditions should consider vaccination.